Pioglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Attenuates Myocardial Ischemia/Reperfusion Injury in a Rat Model

Laboratory Investigation

Volumn 83, Issue 12, 2003, Pages 1715-1721

  Ito, Haruyasu ^a   Nakano, Atsushi ^a   Kinoshita, Makoto ^a   Matsumori, Akira ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN SENSITIZING AGENT; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PHORBOL 13 ACETATE 12 MYRISTATE; PIOGLITAZONE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CELL CULTURE; CELL INFILTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INHIBITION KINETICS; MACROPHAGE ACTIVATION; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ANIMALS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; HYPOGLYCEMIC AGENTS; INTERCELLULAR ADHESION MOLECULE-1; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

EID: 0347995030     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000106724.29121.DA     Document Type: Article

References (35)

1. Ban K, Ikeda U, Takahashi M, Kanbe T, Kasahara T, and Shimada K (1994). Expression of intercellular adhesion molecule-1 on rat cardiac myocytes by monocyte chemoattractant protein-1. Cardiovasc Res 28:1258-1262.
2. Behr TM, Wang X, Aiyar N, Coatney RW, Li X, Koster P, Angermann CE, Ohlstein E, Feuerstein GZ, and Winaver J (2000). Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure. Circulation 102:1315-1322.
3. Braunwald E and Kloner RA (1985). Myocardial reperfusion: A double-edged sword? J Clin Invest 76:1713-1719.
4. Camp HS, Li O, Wise SC, Hong YH, Frankowski CL, Shen X, Vanbogelen R, and Leff T (2000). Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes 49:539-547.
5. Chawla A, Schwarz EJ, Dimaculangan DD, and Lazar MA (1994). Peroxisome proliferator-activated receptor (PPAR) gamma: Adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135:798-800.
6. Desreumaux P, Dubuquoy L, Nutten S, Peuchmaur M, Englaro W, Schoonjans K, Derijard B, Desvergne B, Wahli W, Chambon P, Leibowitz MD, Colombel JF, and Auwerx J (2001). Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer: A basis for new therapeutic strategies. J Exp Med 193:827-838.
7. Gumina RJ, el Schultz J, Yao Z, Kenny D, Warltier DC, Newman PJ, and Gross GJ (1996). Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury. Circulation 94:3327-3333.
8. Hartman JC, Anderson DC, Wiltse AL, Lane CL, Rosenbloom CL, Manning AM, Humphrey WR, Wall TM, and Shebuski RJ (1995). Protection of ischemic/reperfused canine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1. Cardiovasc Res 30:47-54.
9. Haslinger B, Mandl-Weber S, Sellmayer A, Lederer SR, and Sitter T (2001). Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: Involvement of protein kinase C. Nephron 87:346-351.
10. Herskowitz A, Choi S, Ansari AA, and Wesselingh S (1995). Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 146:419-428.
11. Ikeda U, Ikeda M, Seino Y, Takahashi M, Kasahara T, Kano S, and Shimada K (1993). Expression of intercellular adhesion molecule-1 on rat vascular smooth muscle cells by proinflammatory cytokines. Atherosclerosis 104:61-68.
12. Ioculano M, Squadrito F, Altavilla D, Canale P, Squadrito G, Campo GM, Saitta A, and Caputi AP (1994). Antibodies against intercellular adhesion molecule 1 protect against myocardial ischaemia-reperfusion injury in rat. Eur J Pharmacol 264:143-149.
13. Jiang C, Ting AT, and Seed B (1998). PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
14. Kakio T, Matsumori A, Ono K, Ito H, Matsushima K, and Sasayama S (2000). Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart. Lab Invest 80:1127-1136.
15. Kakizaki Y, Waga S, Sugimoto K, Tanaka H, Nukii K, Takeya M, Yoshimura T, and Yokoyama M (1995). Production of monocyte chemoattractant protein-1 by bovine glomerular endothelial cells. Kidney Int 48:1866-1874.
16. Kukielka GL, Hawkins HK, Michael L, Manning AM, Youker K, Lane C, Entman ML, Smith CW, and Anderson DC (1993). Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. J Clin Invest 92:1504-1516.
17. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, and Kliewer SA (1997). Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272:3406-3410.
18. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, and Kliewer SA (1995). An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270:12953-12956.
19. Lemberger T, Desvergne B, and Wahli W (1996). Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 12:335-363.
20. Maeshiba Y, Kiyota Y, Yamashita K, Yoshimura Y, Motohashi M, and Tanayama S (1997). Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys. Arzneim Forsch Drug Res 47:29-35.
21. Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, Matsushima K, and Sasayama S (1997). Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 29:419-423.
22. Ono K, Matumori A, Furukawa Y, Igata H, Shioi T, Matsushima K, and Sasayama S (1999). Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab Invest 79:195-203.
23. Ono K, Matsumori A, Shioi T, Furukawa Y, and Sasayama S (1998). Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling. Circulation 98:149-156.
24. Ricote M, Li AC, Willson TM, Kelly CJ, and Glass CK (1998). The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82.
25. Robinson EA, Yoshimura T, Leonard EJ, Tanaka S, Griffin PR, Shabanowitz J, Hunt DF, and Appella E (1989). Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. Proc Natl Acad Sci USA 86:1850-1854.
26. Rollins BJ, Stier P, Ernst T, and Wong GG (1989). The human homolog of the JE gene encodes a monocyte secretory protein. Mol Cell Biol 9:4687-4695.
27. Sakamoto J, Kimura H, Moriyama S, Odaka H, Momose Y, Sugiyama Y, and Sawada H (2000). Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone. Biochem Biophys Res Commun 278:704-711.
28. Schoonjans K and Auwerx J (2000). Thiazolidinediones: An update. Lancet 355:1008-1010.
29. Shioi T, Matsumori A, Kihara Y, Inoko M, Ono K, Iwanaga Y, Yamada T, Iwasaki A, Matsushima K, and Sasayama S (1997). Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ Res 81:664-671.
30. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, and Wu GD (1999). A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 104:383-389.
31. Tontonoz P, Hu E, and Spiegelman BM (1994). Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79:1147-1156.
32. Uchimura K, Nakamuta M, Enjoji M, Irie T, Sugimoto R, Muta T, Iwamoto H, and Nawata H (2001). Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells. Hepatology 33:91-99.
33. Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatterjee PK, and Thiemermann C (2002). Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J 16:1027-1040.
34. Yue TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, Hart TK, Buckingham RE, and Ohistein EH (2001). In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation 104:2588-2594.
35. Zachariae CO, Anderson AO, Thompson HL, Appella E, Mantovani A, Oppenheim JJ, and Matsushima K (1990). Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med 171:2177-2182.